Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

4 Stocks to Sell Before the Bear Market Comes

Retail investors are looking for stocks to sell as the second Covid-19 wave threatens to wipe up a sizable chunk of the markets again.

Accounting Misdirection Could Send Array Technologies Stock Falling 50%

Array Technologies stock will drop 50% unless the company can extend innovation from its accounting department to its engineering one.

Exxon Mobil Stock Is Becoming Increasingly Irrelevant by the Day

With Americans seemingly favoring Joe Biden, the political environment doesn’t favor XOM stock. But even if Trump wins reelection, the calls for cleaner energy will not die.

While There’s Light In Sight, General Electric Remains Risky

GE stock crushed expectations in a third quarter earnings report. But lingering fraud allegations and pension woes must be addressed.

Despite Covid-19 Surge, Sit Things Out With XpresSpa Stock

With novel coronavirus cases on the rise again, can XpresSpa stock make a comeback? It's debatable, so sit out on this pandemic play.

There’s No Proof Yet That Luckin Coffee Deserves Investment

Without accurate numbers and proof it has been reformed, don’t be too eager to put your money into questionable Luckin stock.

3 Car Stocks to Leave on the Lot as Americans Drive Less

Strict social distancing and stay-at-home regulation are hammering car stocks, but these companies are faring worse than the industry.

Not a Pretty Picture, Kodak Stock Looks Like a Really Risky Bet Right Now

Kodak stock declines as allegations surrounding the company’s questionable actions prior to the loan announcement continue to swirl. Here’s why KODK stock is a risky investment.

Avoid Inovio Pharmaceuticals Stock Until the FDA Greenlights Trials

While I’d like to tell you Inovio Pharmaceuticals is a blood-in-the-streets opportunity, I can’t. Avoid INO stock for now.

Cloudflare Looks Overvalued Amid Threat From Fastly

In a development that could hurt NET stock down the road, highly innovative Fastly is taking steps to improve its IT security capabilities,

3 Utility Stocks to Avoid Now Amid Upcoming Headwinds

Utility stocks have a tailwind thanks to central banks' actions. But investors can find better spots to invest because of looming resistance.

Hyliion Stock Isn’t Worth Your Money At This Point

Hyliion stock might interest investors as part of the broader rush toward SPAC stocks. But not at this point. Here's more about its troubles.

IBIO Stock Remains a Speculative Biopharma Play

Yes, I will continue to root for Ibio in its fight to make a huge leap with its Covid-19 efforts. But where my investment dollar is concerned, it'll be from the sidelines.

Owning Westwater Resources Stock May Challenge Investors With a Social Conscience

Graphite miner Westwater Resources presents investors with a dilemma. The more they learn about the proces, the less appealing WWR stock may seem.

This Downtrend in AMC Entertainment Stock Won’t End Anytime Soon

Contrarians like to buy when prices are low, but jumping into the trade with AMC stock today would be like trying to catch a falling knife.

This Rally in Hertz Will End Just Like the Others — Badly

Hertz stock soared this month on a financing deal. But that keeps the company in bankruptcy, which still makes its equity a likely zero.

With the Election Looming, Palantir Stock Looks Too Risky

A Biden administration would be unlikely to utilize Palantir a great deal, hurting PLTR stock.

3 Work-From-Home Stocks Whose Time Is Running Out

Peleton, Domino's and DocuSign are work-from-home stocks whose time is running out. As the pandemic eases, their growth will slow.

Avoid Kodak Stock At All Costs — This Will Not End Well

Kodak stock has been volatile, as it was thrust from irrelevance to the front pages. But this is a no-touch for us.